A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients

Clinical trial NCT01225081 · COMPLETED

Trial details

NCT number: NCT01225081
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus

Start date: 2010-09-15
Primary completion: 2012-04-28
Enrollment: 152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.